secwatch.observer — SEC 8-K summary
======================================

Issuer:     22nd Century Group, Inc. (XXII)
CIK:        0001347858
Form:       8-K
Filed at:   2022-06-15T23:59:59+00:00
Accession:  0001104659-22-071471
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

22nd Century Group appoints R. Hugh Kinsman as CFO, replacing Richard Fitzgerald
--------------------------------------------------------------------------------

- Kinsman, formerly CFO of acquired GVB Biopharma, becomes CFO effective June 15, 2022.
- Former CFO Richard Fitzgerald permanently separated on June 13, 2022.
- Three-year employment agreement with initial base salary of $290,000.
- Severance of 12 months base salary if terminated without cause, plus health coverage.
- Press release highlights rapid integration of GVB Biopharma and VLN cigarette launch.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347858/000110465922071471/0001104659-22-071471-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347858/000110465922071471/tm2218497d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-071471

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer